- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Winter Park, Florida, United States
- Baltimore, Maryland, United States
- Houston, Texas, United States
- Vienna, Austria
Clinical trial condition
Primary Myelofibrosis
Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.
453 public trials
89 recruiting studies
Primary Myelofibrosis trial results
NCT02722668
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, +74 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT01290302
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +23 more
- Locations
-
- Luitpold Pharmaceuticals, Inc. Norristown, Pennsylvania, United States
NCT01375140
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +8 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT02988466
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Failure Disorders, +53 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT05665192
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Cardinal Health Specialty Solutions Dublin, Ohio, United States
Completed
Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF
NCT01644110
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Universitätsklinikum Aachen - Med. Klinik IV Aachen, Germany
- Hämatologisch onkologische Praxis Augsburg, Germany
- Helios Klinikum Bad Saarow Bad Saarow, Germany
- Klinik für Innere Medizin Uniklinik Köln Cologne, Germany
NCT00719888
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +65 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
NCT00724334
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Investigational Site Number 840103 La Jolla, California, United States
- Investigational Site Number 840102 Stanford, California, United States
- Investigational Site Number 840105 Boston, Massachusetts, United States
- Investigational Site Number 840106 Ann Arbor, Michigan, United States
NCT01692366
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Investigational Site Number 392010 Akita, Japan
- Investigational Site Number 392002 Bunkyō City, Japan
- Investigational Site Number 392006 Bunkyō City, Japan
- Investigational Site Number 392004 Sendai, Japan